The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Subgroup analysis of patients enrolled in the United States in the CORRECT phase 3 trial of the multikinase inhibitor regorafenib (REG) in metastatic colorectal cancer (mCRC).
 
George P. Kim
Employment - 21st Century Oncology
Honoraria - Celgene; Genentech; Gilead Sciences; Merrimack
Consulting or Advisory Role - Celgene; Genentech; Gilead Sciences; Merrimack
Speakers' Bureau - Celgene; Genentech
Research Funding - Genentech; Lilly
Travel, Accommodations, Expenses - Celgene; Genentech
 
Eric Van Cutsem
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
Heinz-Josef Lenz
Honoraria - Bayer; Celgene; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Celgene; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Udit N. Verma
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer
 
Marc Saltzman
Consulting or Advisory Role - Bayer
Speakers' Bureau - Archimedes
Research Funding - Bayer; Cubist; Hospira; Merck
 
Jyotsna Fuloria
No Relationships to Disclose
 
Ali Khojasteh
No Relationships to Disclose
 
Martin Wiesenfeld
No Relationships to Disclose
 
Frank Cihon
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Andrea Wagner
Employment - Bayer
 
Axel Grothey
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche